医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial

广告
第一作者: Correale,P.
作者单位: Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Via [1] Department of Biotechnology, Siena University Hospital SantaMaria Alle Scotte, Istituto Toscano [2] Department of Legal, Historical, Economic and Social Sciences-DSGSES, Magna Graecia University of [3] Pharmacy Unit, Siena University Hospital SantaMaria Alle Scotte, Istituto Toscano Tumory, Siena [4] Medical Oncology Unit, Siena University Hospital SantaMaria Alle Scotte, Istituto Toscano Tumory [5] Radiotherapy Unit, Siena University Hospital SantaMaria Alle Scotte, Istituto Toscano Tumory, Siena [6] Medical Oncology Unit, Centro Oncologico Romagnolo, Forlì, Italy [7] Medical Oncology Unit, Department of Oncology, Microbiology Section, Siena, Italy [8] Chemotherapy Unit, Department of Oncology, Florence University School of Medicine, Florence, Italy [9] Medical Oncology Unit, Department of Oncology, Cagliari University School of Medicine, Cagliari [10] Rheumatology Unit, Department of Medicine, Istituto Toscano Tumory, Siena, Italy [11]
发布时间 2014-03-22
提交
  • 浏览0
Journal of immunotherapy

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷